Next-generation nanoparticles for cancer and autoimmune therapy
<p>Immune modulation is a critical therapeutic approach for cancer and autoimmune diseases, aiming to balance immune activation and suppression within specific disease environments. Next-generation nanoparticles (NPs) offer a promising method for precisely delivering cytokines and other immune...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513539914334208 |
|---|---|
| author | Alshayma N. Al-Thani (17976380) |
| author2 | Asma Ghafoor Jan (19736878) Zainab Hajialthakar (22254328) Ahmed Awad (6052524) Mohamed Abbas (834428) |
| author2_role | author author author author |
| author_facet | Alshayma N. Al-Thani (17976380) Asma Ghafoor Jan (19736878) Zainab Hajialthakar (22254328) Ahmed Awad (6052524) Mohamed Abbas (834428) |
| author_role | author |
| dc.creator.none.fl_str_mv | Alshayma N. Al-Thani (17976380) Asma Ghafoor Jan (19736878) Zainab Hajialthakar (22254328) Ahmed Awad (6052524) Mohamed Abbas (834428) |
| dc.date.none.fl_str_mv | 2025-09-01T06:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1016/j.bcp.2025.117298 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Next-generation_nanoparticles_for_cancer_and_autoimmune_therapy/30135175 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Immunology Oncology and carcinogenesis Engineering Biomedical engineering Nanotechnology Nanoparticles (NPs) Immune modulation Cytokines immune checkpoint inhibitors (ICIs) Immune therapy Autoimmune disease Cancer |
| dc.title.none.fl_str_mv | Next-generation nanoparticles for cancer and autoimmune therapy |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p>Immune modulation is a critical therapeutic approach for cancer and autoimmune diseases, aiming to balance immune activation and suppression within specific disease environments. Next-generation nanoparticles (NPs) offer a promising method for precisely delivering cytokines and other immune modulators, addressing challenges such as systemic toxicity and limited specificity. This review explores the dual function of NPs in modulating pro- and anti-inflammatory responses, enhancing immune detection and tumor elimination in cancer, while promoting immune tolerance in autoimmune diseases. Advanced NP design strategies are highlighted, including stimuli-responsive systems tailored for the tumor microenvironment (TME) and inflamed tissues, as well as co-delivery platforms that combine cytokines with immune checkpoint inhibitors (ICIs). Additionally, dual-function NPs designed to target multiple immune pathways simultaneously are examined, offering innovative solutions for complex diseases. Despite ongoing challenges related to compatibility, safety, and scalability, the integration of nanotechnology with immune modulation presents significant potential to transform therapeutic outcomes. Future research should focus on overcoming these limitations to enhance clinical applications. By leveraging the precision and adaptability of next-generation NPs, a new frontier in immune therapy is emerging, offering more effective and targeted treatments for cancer and autoimmune diseases.</p><h2>Other Information</h2> <p> Published in: Biochemical Pharmacology<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.bcp.2025.117298" target="_blank">https://dx.doi.org/10.1016/j.bcp.2025.117298</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_f775bec59dad2ba7b3e01b61a9c2d3e0 |
| identifier_str_mv | 10.1016/j.bcp.2025.117298 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/30135175 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Next-generation nanoparticles for cancer and autoimmune therapyAlshayma N. Al-Thani (17976380)Asma Ghafoor Jan (19736878)Zainab Hajialthakar (22254328)Ahmed Awad (6052524)Mohamed Abbas (834428)Biomedical and clinical sciencesImmunologyOncology and carcinogenesisEngineeringBiomedical engineeringNanotechnologyNanoparticles (NPs)Immune modulationCytokinesimmune checkpoint inhibitors (ICIs)Immune therapyAutoimmune diseaseCancer<p>Immune modulation is a critical therapeutic approach for cancer and autoimmune diseases, aiming to balance immune activation and suppression within specific disease environments. Next-generation nanoparticles (NPs) offer a promising method for precisely delivering cytokines and other immune modulators, addressing challenges such as systemic toxicity and limited specificity. This review explores the dual function of NPs in modulating pro- and anti-inflammatory responses, enhancing immune detection and tumor elimination in cancer, while promoting immune tolerance in autoimmune diseases. Advanced NP design strategies are highlighted, including stimuli-responsive systems tailored for the tumor microenvironment (TME) and inflamed tissues, as well as co-delivery platforms that combine cytokines with immune checkpoint inhibitors (ICIs). Additionally, dual-function NPs designed to target multiple immune pathways simultaneously are examined, offering innovative solutions for complex diseases. Despite ongoing challenges related to compatibility, safety, and scalability, the integration of nanotechnology with immune modulation presents significant potential to transform therapeutic outcomes. Future research should focus on overcoming these limitations to enhance clinical applications. By leveraging the precision and adaptability of next-generation NPs, a new frontier in immune therapy is emerging, offering more effective and targeted treatments for cancer and autoimmune diseases.</p><h2>Other Information</h2> <p> Published in: Biochemical Pharmacology<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.bcp.2025.117298" target="_blank">https://dx.doi.org/10.1016/j.bcp.2025.117298</a></p>2025-09-01T06:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.bcp.2025.117298https://figshare.com/articles/journal_contribution/Next-generation_nanoparticles_for_cancer_and_autoimmune_therapy/30135175CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/301351752025-09-01T06:00:00Z |
| spellingShingle | Next-generation nanoparticles for cancer and autoimmune therapy Alshayma N. Al-Thani (17976380) Biomedical and clinical sciences Immunology Oncology and carcinogenesis Engineering Biomedical engineering Nanotechnology Nanoparticles (NPs) Immune modulation Cytokines immune checkpoint inhibitors (ICIs) Immune therapy Autoimmune disease Cancer |
| status_str | publishedVersion |
| title | Next-generation nanoparticles for cancer and autoimmune therapy |
| title_full | Next-generation nanoparticles for cancer and autoimmune therapy |
| title_fullStr | Next-generation nanoparticles for cancer and autoimmune therapy |
| title_full_unstemmed | Next-generation nanoparticles for cancer and autoimmune therapy |
| title_short | Next-generation nanoparticles for cancer and autoimmune therapy |
| title_sort | Next-generation nanoparticles for cancer and autoimmune therapy |
| topic | Biomedical and clinical sciences Immunology Oncology and carcinogenesis Engineering Biomedical engineering Nanotechnology Nanoparticles (NPs) Immune modulation Cytokines immune checkpoint inhibitors (ICIs) Immune therapy Autoimmune disease Cancer |